- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG in China
Total 43 results
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)China
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Binhui Biopharmaceutical Co., Ltd.RecruitingNon-muscle-invasive Bladder CancerChina
-
RenJi HospitalBeiGene; RemeGen Co., Ltd.RecruitingHER2 | Non-Muscle Invasive Bladder CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Huazhong University of Science and TechnologyRecruitingBladder Cancer | Non-Muscle-Invasive Bladder CancerChina
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Chengdu CoenBiotech Co., LtdSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Ruijin HospitalNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Qilu Pharmaceutical Co., Ltd.RecruitingNon-Muscle Invasive Bladder CancerChina
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisActive, not recruiting
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruiting
-
West China HospitalRemeGen Co., Ltd.Not yet recruitingNon-muscle Invasive Bladder CancerChina
-
CG Oncology, Inc.RecruitingNon Muscle Invasive Bladder Cancer | High-grade Ta/ T1 Papillary Disease Bladder CancerUnited States, Korea, Republic of, Taiwan, Japan, Australia
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Qilu Hospital of Shandong UniversityRecruiting
-
Ferring PharmaceuticalsRecruiting
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group LimitedUnknownMuscle Invasive Bladder CancerChina
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom, China, Japan, Brazil, Argentina
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
Ruijin HospitalNot yet recruitingMuscle-Invasive Bladder CarcinomaChina
-
Tianjin Medical University Second HospitalRecruitingMuscle Invasive Bladder Cancer Urothelial CarcinomaChina
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Tianjin Medical University Second HospitalActive, not recruitingUrothelial Carcinoma | Muscle Invasive Bladder CancerChina
-
Tianjin Medical University Second HospitalRecruitingHigh-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Tianjin Medical University Second HospitalRecruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | High-RiskChina
-
Tianjin Medical University Second HospitalRecruitingHer2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Zhujiang HospitalRecruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingArtificial Intelligence | Muscle-invasive Bladder CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Peking University First Hospital; China-Japan Friendship HospitalRecruitingMuscle-invasive Bladder Cancer | Upper Tract Urinary CarcinomaChina
-
RenJi HospitalRecruitingRadiotherapy | Muscle Invasive Bladder Cancer | PD-1 | HER2 Expression | Antibody-drug ConjugatesChina
-
Chengdu CoenBiotech Co., LtdHunan Cancer HospitalCompleted
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Recruiting
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Henan Cancer HospitalRecruitingIntraoperative Complications | Perfusion; Complications | High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditionsUnited States